Abstract
Three specific patterns of meperidine metabolism were observed in the maternal serum of 52 patients studied. These patterns appear to be related to the rate of formation of certain metabolites of the compound. No observable signs of infant depression were detectable when delivery was performed during the first 60 minutes following the administration of the analgesic agent regardless of the type of pattern. However, when greater than 60 minutes had elapsed following intravenous injection of meperidine the incidence of depressed infants was directly related to the more rapid metabolic patterns. Therefore, the most significant factors relating infant depression to meperidine are the maternal metabolic pattern and the length of time the patient is in labor following the administration of the compound. These observations presumably reflect the increased toxicity of certain metabolites of meperidine transferred to the fetus from the mother. Thus, if delivery takes place within 60 minutes after injection, the level of metabolites of meperidine in the fetus should be low and the chance of a depressed infant reduced.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
